These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26995171)

  • 1. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical issues and stakeholders matter.
    Dale O
    Addiction; 2016 Apr; 111(4):587-9. PubMed ID: 26995170
    [No Abstract]   [Full Text] [Related]  

  • 3. Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxone.
    Lobmaier PP; Clausen T
    Addiction; 2016 Apr; 111(4):586-7. PubMed ID: 26995169
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
    Strang J; McDonald R; Tas B; Day E
    Addiction; 2016 Apr; 111(4):574-82. PubMed ID: 26840916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
    Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
    J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonprescription availability of the opioid antagonist naloxone.
    Landers A
    Am J Health Syst Pharm; 2018 Jul; 75(14):1069-1072. PubMed ID: 29789317
    [No Abstract]   [Full Text] [Related]  

  • 10. Tangled-up and blue: releasing the regulatory chokehold on take-home naloxone.
    Winstanley EL
    Addiction; 2016 Apr; 111(4):583-4. PubMed ID: 26995167
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing opioid overdose in pregnancy with take-home naloxone.
    Blandthorn J; Bowman E; Leung L; Bonomo Y; Dietze P
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):460-462. PubMed ID: 29271100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Outcomes of Opioid Overdose: Preparing Nursing Students to Intervene.
    Dion KA
    J Addict Nurs; 2016; 27(1):7-11. PubMed ID: 26950837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose prevention: naloxone with long acting opioids.
    Bowman S; McKenzie M; Rich J
    Med Health R I; 2008 Sep; 91(9):271-2. PubMed ID: 18834043
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina.
    Davis CS; Walley AY; Bridger CM
    J Law Med Ethics; 2015; 43 Suppl 1():19-22. PubMed ID: 25846157
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.
    Drainoni ML; Koppelman EA; Feldman JA; Walley AY; Mitchell PM; Ellison J; Bernstein E
    BMC Res Notes; 2016 Oct; 9(1):465. PubMed ID: 27756427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.